Defining the Erythrocyte Binding Domains of Plasmodium vivax Tryptophan Rich Antigen 33.5

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Bora, Hema ^a   Tyagi, Rupesh Kumar ^a   Sharma, Yagya Dutta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; P4 PEPTIDE; P8 PEPTIDE; POLYCLONAL ANTIBODY; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; TRYPTOPHAN RICH ANTIGEN 33.5 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; PEPTIDE FRAGMENT; PROTEIN BINDING; TRYPTOPHAN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CONTROLLED STUDY; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; MIDDLE TERMINAL SEQUENCE; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; PLASMODIUM VIVAX; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM VIVAX MALARIA; PROTEIN TERTIARY STRUCTURE;

ORYCTOLAGUS CUNICULUS; PLASMODIUM VIVAX;

AMINO ACID SEQUENCE; ANIMALS; ERYTHROCYTES; HUMANS; MALARIA, VIVAX; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMODIUM VIVAX; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; TRYPTOPHAN;

EID: 84876736094     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062829     Document Type: Article

References (37)

1. Garcia LS, (2010) Malaria. Clin Lab Med 30: 93-129.
2. Burns JM Jr, Dunn PD, Russo DM, (1997) Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens. Infect Immun 65: 3138-3145.
3. Burns JM Jr, Adeeku EK, Dunn PD, (1999) Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes. Infect Immun 67: 675-680.
4. Uhlemann AC, Oguariri RM, McColl DJ, Coppel RL, Kremsner PG, et al. (2001) Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii. Mol Biochem Parasitol 118: 41-48.
5. Ntumngia FB, Bouyou-Akotet MK, Uhlemann AC, Mordmuller B, Kremsner PG, et al. (2004) Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites. Mol Biochem Parasitol 137: 349-353.
6. Curtidor H, Ocampo M, Rodriguez LE, Lopez R, Garcia JE, et al. (2006) Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes. Biochem Biophys Res Commun 339: 888-896.
7. Ntumngia FB, Bahamontes-Rosa N, Kun JF, (2005) Genes coding for tryptophan-rich proteins are transcribed throughout the asexual cycle of Plasmodium falciparum. Parasitol Res 96: 347-353.
8. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, et al. (2008) Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455: 757-763.
9. Tachibana S, Sullivan SA, Kawai S, Nakamura S, Kim HR, et al. (2012) Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade. Nat Genet 44: 1051-1055.
10. Jalah R, Sarin R, Sud N, Alam MT, Parikh N, et al. (2005) Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Mol Biochem Parasitol 142: 158-169.
11. Alam MT, Bora H, Mittra P, Singh N, Sharma YD, (2008) Cellular immune responses to recombinant Plasmodium vivax tryptophan-rich antigen (PvTRAg) among individuals exposed to vivax malaria. Parasite Immunol 30: 379-383.
12. Alam MT, Bora H, Singh N, Sharma YD, (2008) High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74). Vaccine 26: 3787-3794.
13. Bora H, Garg S, Sen P, Kumar D, Kaur P, et al. (2011) Plasmodium vivax tryptophan-rich antigen PvTRAg33.5 contains alpha helical structure and multidomain architecture. PLoS One 6: e16294.
14. Garg S, Chauhan SS, Singh N, Sharma YD, (2008) Immunological responses to a 39.8 kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg39.8) among humans. Microbes Infect 10: 1097-1105.
15. Mittra P, Singh N, Sharma YD, (2010) Plasmodium vivax: immunological properties of tryptophan-rich antigens PvTRAg 35.2 and PvTRAg 80.6. Microbes Infect 12: 1019-1026.
16. Siddiqui AA, Bora H, Singh N, Dash AP, Sharma YD, (2008) Expression, purification, and characterization of the immunological response to a 40-kilodalton Plasmodium vivax tryptophan-rich antigen. Infect Immun 76: 2576-2586.
17. Siddiqui AA, Singh N, Sharma YD, (2007) Expression and purification of a Plasmodium vivax antigen- PvTARAg55 tryptophan- and alanine-rich antigen and its immunological responses in human subjects. Vaccine 26: 96-107.
18. Tyagi RK, Sharma YD, (2012) Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies. PLoS One 7: e50754.
19. Zeeshan M, Bora H, Sharma YD, (2012) Presence of memory T cells and naturally acquired antibodies in Plasmodium vivax malaria-exposed individuals against a group of tryptophan-rich antigens with conserved sequences. J Infect Dis 207: 175-185.
20. Espinosa AM, Sierra AY, Barrero CA, Cepeda LA, Cantor EM, et al. (2003) Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments. Vaccine 21: 1033-1043.
21. Sarin R, Sharma YD, (2006) Thioredoxin system in obligate anaerobe Desulfovibrio desulfuricans: Identification and characterization of a novel thioredoxin 2. Gene 376: 107-115.
22. Burns JM, Adeeku EK, Belk CC, Dunn PD, (2000) An unusual tryptophan-rich domain characterizes two secreted antigens of Plasmodium yoelii-infected erythrocytes. Mol Biochem Parasitol 110: 11-21.
23. Haynes JD, Dalton JP, Klotz FW, McGinniss MH, Hadley TJ, et al. (1988) Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J Exp Med 167: 1873-1881.
24. Duraisingh MT, Maier AG, Triglia T, Cowman AF, (2003) Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and-independent pathways. Proc Natl Acad Sci U S A 100: 4796-4801.
25. Reed MB, Caruana SR, Batchelor AH, Thompson JK, Crabb BS, et al. (2000) Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion. Proc Natl Acad Sci U S A 97: 7509-7514.
26. Sahar T, Reddy KS, Bharadwaj M, Pandey AK, Singh S, et al. (2011) Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS One 6: e17102.
27. Gilberger TW, Thompson JK, Triglia T, Good RT, Duraisingh MT, et al. (2003) A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol Chem 278: 14480-14486.
28. Lobo CA, Rodriguez M, Reid M, Lustigman S, (2003) Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl). Blood 101: 4628-4631.
29. Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, et al. (2011) Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature: 534-537.
30. Rodriguez M, Lustigman S, Montero E, Oksov Y, Lobo CA, (2008) PfRH5: a novel reticulocyte-binding family homolog of plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor. PLoS One 3: e3300.
31. Corradin G, Kajava AV, Verdini A, (2010) Long synthetic peptides for the production of vaccines and drugs: a technological platform coming of age. Sci Transl Med 2: 50rv53.
32. Curtidor H, Urquiza M, Suarez JE, Rodriguez LE, Ocampo M, et al. (2001) Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine 19: 4496-4504.
33. Obando-Martinez AZ, Curtidor H, Arevalo-Pinzon G, Vanegas M, Vizcaino C, et al. (2010) Conserved high activity binding peptides are involved in adhesion of two detergent-resistant membrane-associated merozoite proteins to red blood cells during invasion. J Med Chem 53: 3907-3918.
34. Obando-Martinez AZ, Curtidor H, Vanegas M, Arevalo-Pinzon G, Patarroyo MA, et al. (2010) Conserved regions from Plasmodium falciparum MSP11 specifically interact with host cells and have a potential role during merozoite invasion of red blood cells. J Cell Biochem 110: 882-892.
35. Pinzon CG, Curtidor H, Bermudez A, Forero M, Vanegas M, et al. (2008) Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC. Vaccine 26: 853-862.
36. Puentes A, Garcia J, Vera R, Lopez R, Suarez J, et al. (2004) Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. Vaccine 22: 1150-1156.
37. Urquiza M, Rodriguez LE, Suarez JE, Guzman F, Ocampo M, et al. (1996) Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol 18: 515-526.